← FDA Drug Approvals (Drugs@FDA)
ESLICARBAZEPINE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SPH ZHONGXI PHARM · Approved 2025-11-03
Drug application
- FDA Application #
ANDA211247- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESLICARBAZEPINE ACETATE
- Generic name
- Eslicarbazepine Acetate
- Active ingredients
- ESLICARBAZEPINE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SPH ZHONGXI PHARM
- First approval
- 2025-11-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown